You’re invited: Next Taubman Tech Talk

Epigenetic modifications are important drivers of development, health and disease. DNA methylation is one type of epigenetic mark that can be measured in blood or other human samples.

DNA methylation marks are associated with genetics and environmental exposures, which represents a useful tool for public health and medicine.

On Thursday, a Taubman Technology Talk will give an overview of current technologies for DNA methylation measurements, describe methodological challenges associated with these methods, and provide evidence-based opportunities for future DNA methylation studies.

The talk — entitled “DNA methylation technologies:  Existing challenges and new opportunities” — will be presented by Kelly M. Bakulski, Ph.D, assistant professor in the Department of Epidemiology at the U-M School of Public Health.

Bakulski’s research goal is to understand the environmental and genetic etiologies of neurological disorders, including autism spectrum disorder and Alzheimer’s disease. Bakulski incorporates population approaches and laboratory experiments to develop biomarker and cell type tools to better inform epigenetic inferences.

The lecture and a Q&A will take place at 5 p.m. on Thursday, Jan. 16 in the Danto Auditorium of the Frankel Cardiovascular Center. It will be followed by light refreshments. 

There is no charge, but registration is appreciated to assist with catering estimates. Click here to register.